Cholesterol Drives DCM Heart Cell Dysfunction
New research indicates that abnormal cholesterol signaling and accumulation in heart cells contribute to the progression of dilated cardiomyopathy (DCM). Correcting these lipid imbalances in laboratory models helped restore cellular structure and function.
Why it matters
This discovery provides a potential new therapeutic target for treating heart failure, a condition with limited current treatment options.
ABNORMAL cholesterol signalling identified as a key regulator of cardiomyocyte structure and function in new research using patient-derived heart tissue. Findings suggest lipid signalling may contribute directly to disease progression in dilated cardiomyopathy (DCM).
The content is a summary of medical research findings with no subjective framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in